Cleveland Clinic Awarded More Than $7M From Patient-Centered Outcomes Research Institute to Advance Treatment of MS, Hypertension

Cleveland Clinic-Led Trial is the First to Show a Delay in Confirmed Disability Progression in Non-relapsing Secondary Progressive Multiple Sclerosis

Results of the phase 3 HERCULES trial publish in New England Journal of Medicine and suggest the first potential treatment option for this form of the disease

Cleveland Cavaliers and Cleveland Clinic Agree to Historic 25-Year Partnership Extension

The agreement forms one of the longest continuous partnerships between a professional sports organization and a healthcare provider, cementing Cleveland as a world leader in sports performance and medicine.